Henoch-Schönlein purpura laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:


==Laboratory findings==
==Laboratory findings==
The diagnosis is based on the combination of the symptoms, as very few other diseases cause the same symptoms together.  [[Blood test]]s may show elevated [[creatinine]] and [[urea]] levels (in kidney involvement), raised [[IgA]] levels (in about 50%), and raised [[C-reactive protein]] (CRP) or [[erythrocyte sedimentation rate]] (ESR) results; none are specific for Henoch-Schönlein purpura. The [[platelet]] count may be raised, and distinguishes the purpura from diseases in which the low platelets are the cause of the purpura ([[idiopathic thrombocytopenic purpura]], [[thrombotic thrombocytopenic purpura]]).
===Renal disease===
Of the 40% of patients who develop kidney involvement, almost all have evidence (visible or on [[urinalysis]]) of blood in the urine. More than half also have [[proteinuria]] (protein in the urine), which in one eighth is severe enough to cause [[nephrotic syndrome]] (generalised swelling due to low protein content of the blood). While abnormalities on urinalysis may continue for a long time, only 1% of all HSP patients develop [[chronic kidney disease]]. [[Hypertension]] (high blood pressure) may occur. Protein loss and high blood pressure, as well as the features on [[biopsy]] of the kidney if performed, may predict progression to advanced kidney disease. Adults are more likely than children to develop advanced kidney disease.<ref name=Shrestha2006>{{cite journal |author=Shrestha S, Sumingan N, Tan J, ''et al'' |title=Henoch Schönlein purpura with nephritis in adults: adverse prognostic indicators in a UK population |journal=QJM |volume=99 |issue=4 |pages=253–65 |year=2006 |pmid=16565522|doi=10.1093/qjmed/hcl034| url=http://qjmed.oxfordjournals.org/cgi/content/full/99/4/253}}</ref>


==References==
==References==

Revision as of 01:56, 6 February 2018

Henoch-Schönlein purpura Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Henoch-Schönlein purpura from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Henoch-Schönlein purpura laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Henoch-Schönlein purpura laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Henoch-Schönlein purpura laboratory findings

CDC on Henoch-Schönlein purpura laboratory findings

Henoch-Schönlein purpura laboratory findings in the news

Blogs on Henoch-Schönlein purpura laboratory findings

Directions to Hospitals Treating Henoch-Schönlein purpura

Risk calculators and risk factors for Henoch-Schönlein purpura laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory findings

References

Template:WH Template:WS